Psilocybin
First Salts And Polymorphs of 4-OH-DiPT Discovered by Terran Biosciences; Patent Application Filed
A PCT patent application from Terran Biosciences was just published covering their discovery of novel salts and polymorphs of the compound 4-OH-DiPT.
The…
A PCT patent application from Terran Biosciences was just published covering their discovery of novel salts and polymorphs of the compound 4-OH-DiPT, adding another layer of IP intrigue around the lesser-known but potentially important compound.
Salts and Solid Forms of 4-Hydroxy-N,N-Diisopropyltryptamine Hemi-Glutarate and Hemi-Succinate was filed by Terran Biosciences and has claims on salts and polymorphs of 4-OH-DiPT, the same compound that both Mindset Pharma and Reunion Neuroscience have applied for patent claims on.
4-HO-DiPT is a psilocybin-like compound initially researched by the Shulgins and noted for its intense effects and shorter onset and trip time. Reunion and Mindset have been competing over patent claims on this drug, with Reunion recently suing Mindset Pharma over its competing patent.
Terran has been quite busy expanding its development portfolio and IP strategy with several recent announcements (see below). This recent publication marks another milestone from Terran’s chemistry team who have built a robust solid-state chemistry platform. So while companies like Reunion and Mindset Pharma have been publicly dueling over the IP around this compound, it appears that Terran had been working on making advances to the compound’s chemistry and developing these novel approaches that, to our knowledge, others have not yet pursued.
While Terran is developing many compounds in-house, they have announced that they’ve made large data packages and IP portfolios available for licensing and partnerships to help advance the psychedelic industry as a whole, which would certainly be of interest to other companies looking to accelerate the development of their pipelines.
For more on Terran, check out Terran Biosciences announces publication of four patent applications of novel empathogens and Terran Biosciences Announces Licensing Deal with Pierre Fabre for Idazoxan; Completes Development Milestones
The post First Salts And Polymorphs of 4-OH-DiPT Discovered by Terran Biosciences; Patent Application Filed appeared first on Microdose.
psilocybin psychedelic deal mindset pharma mindset-
Psilocybin1 week ago
The Psychedelic Scene in Oaxaca, Mexico
-
Law & Regulation6 days ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psychedelics6 days ago
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
-
Psychedelics6 days ago
MindMed Reports First Quarter 2024 Financial Results and Business Updates
-
Psychedelics1 week ago
Oprah Daily’s Comprehensive Guide to Psychedelics: A Milestone for Industry Acceptance
-
Psychedelics1 week ago
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com
-
Psychedelics1 week ago
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com
-
Psychedelics1 week ago
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones